Preliminary report of phase II study of neoadjuvant chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in locally advanced squamous cell carcinoma of the head and neck cancer (SCCHN) patients

被引：0
|
作者：
Chitapanarux, I.
Lorvidhaya, V.
Tharavichitkul, E.
Sittitrai, R.
Pattarasakulchai, I.
Kamnerdsupaphon, P.
Sukthomyal, V.
机构：
[1] Chiang Mai Univ, Div Therapeut Radiol & Oncol, Chiang Mai, Thailand
[2] Chiang Mai Univ, Dept Otolaryngol, Chiang Mai, Thailand
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：311 / 312
页数：2
相关论文
共 50 条
  • [21] Phase I study of cabazitaxel-PF induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Khan, Adnan
    Babu, Rita
    Vaz, Amiya
    Deyne-Borza, Michele
    Price, Alicia
    Bakst, Richard Lorne
    Gupta, Vishal
    Miles, Brett
    Posner, Marshall R.
    Misiukiewicz, Krzysztof
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Phase II Consolidation Chemotherapy With Ifosfamide and Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Cervix Uteri
    Mahasittiwat, P.
    Ieumwananonthachai, N.
    Setakornnukul, J.
    Soontornpong, N.
    Udompunturak, S.
    Pattaranutraporn, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S452 - S452
  • [23] A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Keam, Bhumsuk
    Lee, Keun-Wook
    Lee, Se-Hoon
    Kim, Jin-Soo
    Kim, Jin Ho
    Wu, Hong-Gyun
    Eom, Keun-Yong
    Kim, Suzy
    Ahn, Soon-Hyun
    Chung, Eun-Jae
    Kwon, Seong Keun
    Jeong, Woo-Jin
    Jung, Young Ho
    Kim, Ji-Won
    Heo, Dae Seog
    ONCOLOGIST, 2019, 24 (06): : 751 - +
  • [24] A Phase II study of Genexol-PM and cisplatin as induction chemotherapy in locally advanced head and neck squamous cell carcinoma
    Lee, Keun-Wook
    Keam, Bhumsuk
    Kim, Jin-Soo
    Lee, Se-Hoon
    CANCER RESEARCH, 2019, 79 (13)
  • [25] Randomised multicentric trial of neoadjuvant chemotherapy in locally advanced squamous cell cervical cancer. Comparison of cisplatin, ifosfamide (IP) versus paclitaxel, cispaltin, ifosfamide (TIP)
    Zanetta, G
    Dell'Anna, T
    Urso, M
    Fiana, L
    Villa, A
    Ratti, M
    TUMORI, 2001, 87 (04) : S131 - S131
  • [26] A phase II study of nimotuzumab and CDDP concurrent with radiation in locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Lim, Wan-Teck
    Ang, Mei-Kim
    Quan Sing Ng
    Wang, Lan-Ying
    Chau, Noan-Minh
    Tan, Daniel S. W.
    Chay, Wen Yee
    Leong, Swan
    Tan, Eng-Huat
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, J. G.
    Kim, D. H.
    Sohn, S. K.
    Baek, J. H.
    Chae, Y. S.
    Lee, K. B.
    Sohn, J. H.
    Park, J. S.
    Kim, J. C.
    Park, I. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 300 - 300
  • [28] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    S K Sohn
    D H Kim
    J H Baek
    S B Jeon
    Y S Chae
    K B Lee
    J S Park
    J H Sohn
    J C Kim
    I K Park
    British Journal of Cancer, 2005, 93 : 1117 - 1121
  • [29] Paclitaxel, Ifosfamide and Cisplatin (TIP) chemotherapy for recurrent or advanced squamous cell cervical cancer (SCCC)
    Zanetta, G
    Fei, F
    Parma, G
    Balestrino, M
    Mangioni, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S231 - S231
  • [30] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Jeon, SB
    Chae, YS
    Lee, KB
    Park, JS
    Sohn, JH
    Kim, JC
    Park, IK
    BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1117 - 1121
12345